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Environmental and genetic factors in etiology of orofacial clefts In Argentina.
M. M. Tofarova1, A.C. Goldberg2, A.CapozzP, M. Pas to Ia, R. Guillen4, and 
fí.P.M.SteegerS'Theunlsserr. University of California San Francisco1 .Marín General 
Hospital2,St.Francis Mem. Hospital3,Californla;Hospital
A.Scaravelii.Tunuyan,Argentina4,University Hospital Nijmegen St Radboud.The 
Netherlands1.
Orofacial clefts (OFC) are common birth defects affecting about 1-2 in every 
1,000 newborns worldwide. Genetic and environmental factors play a role in their 
etiology. Historical and recent studies suggest that a certain proportion of OFC could 
be prevented by periconceptfonal supplementation of FA and multivitamins, in order 
to analyze dietary information, key life style data and other epidemiological 
information, we carried out a case control study in Mendoza, Argentina. Altogether, 
140 families of probands affected with OFC and 110 control families were 
analyzed.During personal interviews of mothers a detailed questionnaire consisting 
of 58 specific questions was filled out.AII probands and controls and all their 
available relatives were examined by medical geneticist. Blood was obtained for 
determination of FA and vitamin B12 levels and for genotyping of 677C~»T MTHFR
gene. 01 the 140 probands, 80 were males and 60 were females; 11 {6 males and 5 
females} had cleft palate and 129 cleft lip with or without cleft palate. In 12 cases 
(8.6%),the OFC was part of a syndrome or a complex of multiple malformations.Both 
cases and controls came from the middle or low social class, In the group of cases, 
there was a higher number of fathers unemployed or working as seasonal 
workers.There was no significant difference in alcohol use or smoking found 
between mothers of cases and controls. For cases, a mean maternal age was 35.3, 
a mean paternal age 39.8,a mean birth weight 3,352 grams. Average size of slbship 
in proband families was 4,0, what was higher than in control families. Data on 
socioeconomlcal status, diet composition, other life-style information, blood ievels of 
FA and vitamins were compared between cases and controls.ln general, the diet of 
families of probands was much simpler than in controls. The results of our study 
suggest important role of exogenous factors in the etiology of OFC In Argentina.
This study was Initiated by ROTAPLAST Intl.,Inc, and supported by ROTAPLAST 
and Dutch Prevention Fund grant.
1238
Associations between luteinizing hormone-fl geno polymorphism and skeletal 
maturation and growth before and during puberty, a  Towno\ J.S. Pn/far, J. 
Blangero3, L  Almasf, M.R. B r o w i T . C .  Murphy*, E.W. Demora th \ A.F. Roche', 
R.M. Sien/ogel\ b rig h t State University, Dayton, OH; ‘ Emory University, Atlanta, 
GA' 3Southwest Foundation for Biomedical Research, San Antonio, TX.
Raivio et al (1997 JCE&M 81:3278-82) reported that Finnish boys hotorozygous 
with a common variant (»-subunit of tho luteinizing hormone (LH-{$) aliólo (arg8, Uir15) 
were shorter and had slower growth rates during puberty than boys homozygous for 
the wild-type LH-tt allele (trpB, Ile15). We examined associations between LH-(i 
lenotvpe determined by PCR and measures of skeletal maturation and growth in
41 children in the Fels Longitudinal Study. A measured genotype analysis was 
performed, allowing for sex-specific trait means, using tho computer package SOLAR 
(Blangero and Almasy 1996). There were 111 boys and 96 girls homozygous for the 
wild-type LH-p allele, and 24 boys and 10 girls heterozygous with the vanant allele, 
Individual growth curves were fitted to serial childhood stature data using tho 
triple loqistic method Implemented in the program AUXAL (Bock ot at. 1994). Age at 
prepubertal minimum height velocity (APPHV) and age at pubertal peak height 
velocity (APHV) were derived, as were height and height velocity at those ciaos. 
These children also had serial skeletal maturity assessments made using the FtLS 
method (Roche et al. 1988), from which skeletal age at APPHV and APHV were
'"^ p a tte rn  of significant, or near significant, associations were found between LH- 
genotype and skeletal maturity ancT height both before and during puberty. LH-. 
heterozygotes were shorter than LH-ll homozygotes at APPHV (p»Q.057), and had 
younger skeletal ages (p=0.059). Similarly, LH-|i heterozygotes wore shorter than LH* 
[} homozygotes at APHV (p»0.077), and had younger sKolotal ages (p®0.036). No 
significant associations were found betweon LH*[) genotype and APPHV, APHV, or 
height velocity at APPHV or APHV. Thus, In our sample of boys and girls, the effects 
of this UH-Í5 polymorphism on both skeletal maturity and height are apparent at the 
onset of tne pubertal growth spurt, and remain evident at the time of maximal
pubertal growth. „ , ,
Supported by NIH grants HD12252, HD26971, HD31G21, DK44297, and
GM18897.
1239
Testing association between candidate-gene markers and phenotype 
in related individuals, by use of estimating equations. David-Alexandre 
Tregouel, Pierre Ducimetiere, and Laurence Tiret. iNSERM Unite 258,
Paris, France.
Association studies are one of the major strategies for identifying genetic 
factors underlying complex traits. In samples of related individuals, 
conventional statistical procedures are not valid for testing association, and 
maximum likelihood (ML) methods have to be used, but they are 
computationally demanding and are not necessarily robust to violations of 
their assumptions. Estimating Equations (EE) offers an alternative to ML 
methods, for estimating association parameters in correlated data. We have 
studied through simulations the behavior of EE in a large range of practical 
situations, including samples of nuclear families of varying sizes and 
mixtures of related and unrelated individuals. For a quantitative phenotype, 
the power of the EE test was comparable to that of a conventional ML test 
and close to the power expected in a sample of unrelated individuals. For a 
binary phenotype, the power of the EE test decreased with the degree of 
clustering, as did the power of the ML test. This result might be partly 
explain by a modeling of the correlations between responses that is less 
efficient tnan that in the quantitative case. In small samples (<50 families), 
the variance of the EE association parameter tended to be underestimated, 
leading to an inflation of the type I error. The heterogeneity of cluster size 
induced a slight loss of efficiency of the EE estimator, by comparison with 
the balanced samples. The major advantages of the EE technique are its 
computational simplicity and its great flexibility, easily allowing investigation 
of gene-gene and gene-environment interactions. It constitutes a powerful 
tool for testing genotype-phenotype association in related individuals.
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LIMB GIRDLE MUSCULAR DYSTROPHY WITH CALPAIN DEFICIENCY IN 
GUIPUZCOA (BASQUE COUNTRY, SPAIN), UrtizbereaJA (1), Urtasun M (3), 
Richard I (2), Saenz A(3), Poza JJ(3)t Cobo AM(3), Lopez de Munain A(3),
Beckmann JS(2), (1) AFM : 1, rue de I'lnternationalo 91000 EVRY - FRANCE (2) 
Genethon ; 1, rue de ('Internationale - 91000 EVRY - FRANCE (3) Hospital N/S 
Aranzazu * 20080 - SAN SEBASTIAN - BASQUE COUNTRY - SPAIN
A survey of limb girdle muscular dystrophy has been carried out In 1995-1996 in 
the Basque province of Guipuzcoa (702,000 Inhabitants). The diagnostic criteria 
were those agreed at the ENMC workshop held in Naarden in 1995. All patients were 
reexamined by two neurologists and underwent electrophysiological and 
immunohlstochemical studies whenever necessary. Serum CK, bidimensfonnal 
echocardiography and respiratory evaluation ware also performed in order to 
investigate phenotypic variations. Genetic studies were carried out at Genethon nnd 
were designed to demonstrate a possible linkage to chromosome 15 ÍLGMD2A 
locus) or to test known mutations. A primary screening enabled to select 62 patients 
out of which 8 turned out to have an alternative diagnosis (2 with Becker muscular 
dystrophy, 3 with SMA, 1 with myotonic dystrophy, 1 with a-sarcoglycanopalhy, 1 
with an undetermined myopathy), and 4 wore not available for tho study. For the 
remaining 51 patients (29 men, 22 women, mean age 38.9 years ± 14.24), the 
clinical presentation was consistent with previous descriptions of LGMD in patients 
reported by M. Fardeati in the Réunion. A molecular screening for CANP3 revealed 
that 29 families corresponding to 38 patients were harbouring a mutation In the 
calpaln gene while the status of tho 13 other patients Is ponding. Interestingly, 18 
families were homozygous for a mutation In oxon 22 whereas 0 families were 
heterozygous for exon 22 and 1 family was homozygous for exon 21. Tho prevalence 
rate of LGMD 2A found in this Basque population (68/100,000) Is one the highest so 
far reported worldwide. This cluster of patients, mostly ot Basquo origin, is 
presumably due to socioeconomlcal (inbreeding, no admixture with neighbouring 
spanish people) and geographical factors. The existence of one main mutation in 
exon 22 suggest a founder effect. Correlations between genotype and phenotype are 
still under way and demonstrates some similarities In tho oxon 22 mutation carriers 
and some discrepancies for the others.
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Presenllins and early-onset Alzheimer’s Disease C.M. van Duijn\ M. 
Crut£, tì. BackhovensP, J. TheunsP. G. Van Gasserà, A. Hofman\ C. Van 
Broeckhoven2. departm ent of Epidemiology & Biostatistics, Erasmus 
University Rotterdam, The Netherlands, 2Neurogenetics Laboratory, 
Flanders Interuniversity Institute for Biotechnology, Born-Bunge Foundation, 
University of Antwerp (UiA), Belgium.
Presenilin 1 (PS-1) and Presenilin 2 (PS-2) mutations have been 
implicated in autosomal dominant forms of early-onset Alzheimer's disease 
(AD). We have conducted a populatlon-basea association study In 102 
patients with early-onset (before age 65 years) AD and 118 age- and sex 
matched controls. For PS-1, two polymorphisms were studied, one in the 
promoter region and one In the 5'UTR region (exon 1B). For PS-2, no 
polymorphisms in the promoter or 5'UTR region were found. Three 
polymorphisms in exon 3 and 4 and intron 11 of PS-2 were studied. The PS-
1 promoter polymorphism was associated to AD (p=0.01; likelihood ratio 
test). The 2-allele of the promoter polymophism was found to be 2.5 times 
increased in AD patients (95% confidence interval: 1.2-5.4). An increased 
frequency was also found if carriers of known PS-1 mutations were 
excluded. Frequencies of the 5'UTR polymorphism in PS-1 (exon 1B) and 
PS-2 polymorphisms in exon 3 and 4 and intron 11 were similar In cases 
and controls, Earlier, we reported an association with two polymorphisms 
flanking the PS-1 promoter polymorphism: at intron 8 (two-fold increase of 
the 22 genotype; p=0.01) and at an upstream marker D14S1028 (3.5-fold 
increase of the 44 genotype; p=0.0005). Together with the present finding 
of an association with the promoter polymorhpmism and early-onset AD, the 
findings of our population-based studies suggest the presence of a 
(common) mutation in the promotor region of PS-1. At the population level, 
we and others have found no evidence for a major role of PS-2 in AD.
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Genetic association of two chromosome 14 gonas (PS1 and ACT) with 
Alzheimer's disease. X, Wang, S X  DeKosky, C,B. Aston m dM .I.
Kamboh. University of Pittsburgh, Pittsburgh, PA,
Alzheimer's disease (AD) Is o multifactorial disease with tho possible 
involvement of several genetic and environmental (actors. Among the 
genetic factors, the gene coding for apolipoprotein E has boen implicated 
with the risk of AD. In this study we have examined tho relationship of two 
candidate genes on chromosome 14, Including presenilin 1 (PS1) and <x 1- 
antichymotrypsin (ACT), with the risk of late-onset AD. The stuay subjects 
included 322 late-onset AD patients and 216 controls. Tho two 
polymorphisms examined were an intronic polymorphism in the PS1 gene 
and a signal peptide polymorphism in the ACT gene. Although the overall 
PS1 genotype distribution showed borderline difference between cases and 
control (p=0.08), the frequencies of PS1/2-1 (53.1% vs. 47.2% p=0.03) and 
PS 1/2*2 (15.2% vs 22.7%; p=0.001) genotypes were significantly different 
between cases and controls. At the ACT locus the frequency of the ACT*A 
allele was significantly higher in cases than controls (0.556 vs. 0,473; 
p=0.006). The stratification of PS1 data by ACT genotypes showed that the 
risk associated with the PS1*1 allele was confined to ACT*A carriers only 
(p=0.038). Similarly, the risk associated with the ACT*A allele was restricted
carriers only (p=0.004). The two-sito haplotype data showed that 
the A l haplotype carrying the ACT*A and PSV1 alleles was more frequent 
In patients than controls (0.316 vs. 0.245; p=:0.009). These data indicate a
possible synergistic effect of these two loci on the risk of AD.
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